These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17285183)

  • 1. Botulinum toxin for post-stroke spastic hypertonia: a review of its efficacy and application in clinical practice.
    Francisco GE
    Ann Acad Med Singap; 2007 Jan; 36(1):22-30. PubMed ID: 17285183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction.
    Sahai A; Khan MS; Fowler C; Dasgupta P
    Urology; 2005 Jan; 65(1):211. PubMed ID: 15667907
    [No Abstract]   [Full Text] [Related]  

  • 3. Fissurectomy combined with anoplasty and injection of botulinum toxin in treatment of anterior chronic anal fissure with hypertonia of internal anal sphincter: a pilot study.
    Patti R; Famà F; Tornambè A; Asaro G; Di Vita G
    Tech Coloproctol; 2010 Mar; 14(1):31-6. PubMed ID: 20127381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hyperfunctional lines of the face with botulinum toxin A.
    Binder WJ; Blitzer A; Brin MF
    Dermatol Surg; 1998 Nov; 24(11):1198-205. PubMed ID: 9834739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke.
    Dunne JW; Gracies JM; Hayes M; Zeman B; Singer BJ;
    Clin Rehabil; 2012 Sep; 26(9):787-97. PubMed ID: 22308557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of botulinum toxin therapy for respiratory distress in patients with cervical hypertonia].
    Hashimoto N; Kagitani-Shimono K; Tominaga K; Kitai Y; Ikeda T; Okinaga T; Taniike M; Ozone K
    No To Hattatsu; 2012 Jan; 44(1):13-8. PubMed ID: 22352024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of botulinum toxin type A against cervical dystonia and muscular hypertonia in persons with severe motor and intellectual disabilities with respiratory problems and/or dysphagia].
    Yokoyama M; Honda M; Okoshi Y; Masuyama T; Iwasaki Y; Arima M
    No To Hattatsu; 2011 Jul; 43(4):273-6. PubMed ID: 21800689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial efficacy of intramuscular injection of botulinum toxin type A against cervical dystonia and general muscular hypertonia in persons with severe motor and intellectual disabilities].
    Adachi M; Saura R
    No To Hattatsu; 2006 Nov; 38(6):425-30. PubMed ID: 17094561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.
    García Salazar LF; dos Santos GL; Pavão SL; Rocha NA; de Russo TL
    Dev Neurorehabil; 2015 Feb; 18(1):1-14. PubMed ID: 25180438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin Injections and Electrical Stimulation for Spastic Paresis Improve Active Hand Function Following Stroke.
    Lee JM; Gracies JM; Park SB; Lee KH; Lee JY; Shin JH
    Toxins (Basel); 2018 Oct; 10(11):. PubMed ID: 30366407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy.
    Willis AW; Crowner B; Brunstrom JE; Kissel A; Racette BA
    Dev Med Child Neurol; 2007 Nov; 49(11):818-22. PubMed ID: 17979859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin treatment of lumbrical spasticity: a brief report.
    Palmer DT; Horn LJ; Harmon RL
    Am J Phys Med Rehabil; 1998; 77(4):348-50. PubMed ID: 9715926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Using botulinum toxin (Botox) for treatment of patients with postroke spasticity].
    Khat'kova SE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):87-90. PubMed ID: 19685598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.